Efficacy and safety of omalizumab in Chinese patients with anti-histamine refractory chronic spontaneous urticaria.
Yuan W, Hu S, Li M, Yang L, Liu L, Zheng M, Guo Z, Song Z, Zhang C, Diao Q, Xu J, Richard A, Patwardhan M, Lyu T, Uddin A, Fogel R, Ligueros-Saylan M, Zheng J.
Yuan W, et al. Among authors: hu s.
Dermatol Ther. 2022 Apr;35(4):e15303. doi: 10.1111/dth.15303. Epub 2022 Jan 17.
Dermatol Ther. 2022.
PMID: 34984792
Free PMC article.
Clinical Trial.